{
  "_id": "753ced43ca2bcdab04e4a1a6f7609526e7f189d4c12129b4316c37eaf0f99248",
  "feed": "market-watch",
  "title": "J&J: Study shows ‘real world evidence' of COVID vaccine's protection against breakthrough infection",
  "text": "<p>J&amp;J JNJ said the new study posted on medRxiv “comprehensively looked at the durability profiles for all three vaccines authorized or approved in the U.S. using the same methodology across three outcomes of interest: COVID-19 breakthrough infections, hospitalizations, and ICU admissions.”</p><p>Last week, the company said its booster vaccine for COVID-19 was 85% effective against hospitalization in a study conducted in South Africa after the omicron variant became dominant.</p>",
  "published": "2022-01-06T21:58:00.000Z",
  "tags": [
    {
      "id": "US4781601046",
      "name": "Johnson & Johnson",
      "offsets": [
        {
          "start": 0,
          "end": 3
        }
      ],
      "nexusId": "10010560"
    }
  ]
}